Literature DB >> 2265025

Nucleotide sequence of a Ugandan HIV-1 provirus reveals genetic diversity from other HIV-1 isolates.

J D Oram1, R G Downing, M Roff, J C Clegg, D Serwadda, J W Carswell.   

Abstract

A Ugandan isolate of human immunodeficiency virus type 1 (HIV-1), designated U455, was adapted to growth in U937 cells, the provirus cloned into the lambda L47.1 vector, and its DNA sequence determined. The sequences of some of the U455 genes showed a marked divergence from those of North American and other African isolates. The sequenced clone was defective with single in-phase stop codons in the vpr and env genes and frame shift, resulting in a stop codon, within the vpu gene.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2265025     DOI： 10.1089/aid.1990.6.1073

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  10 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.

Authors:  P R Clapham; D Blanc; R A Weiss
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

3.  Isolation of a highly cytopathic lentivirus from a nondomestic cat.

Authors:  M C Barr; L Zou; D L Holzschu; L Phillips; F W Scott; J W Casey; R J Avery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia.

Authors:  Stanley A Trask; Cynthia A Derdeyn; Ulgen Fideli; Yalu Chen; Sreelatha Meleth; Francis Kasolo; Rosemary Musonda; Eric Hunter; Feng Gao; Susan Allen; Beatrice H Hahn
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.

Authors:  J R Neilson; G C John; J K Carr; P Lewis; J K Kreiss; S Jackson; R W Nduati; D Mbori-Ngacha; D D Panteleeff; S Bodrug; C Giachetti; M A Bott; B A Richardson; J Bwayo; J Ndinya-Achola; J Overbaugh
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

6.  Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).

Authors:  Carolyne Onyango-Makumbi; Saad B Omer; Michael Mubiru; Lawrence H Moulton; Clemensia Nakabiito; Philippa Musoke; Francis Mmiro; Sheryl Zwerski; Hans Wigzell; Lars Falksveden; Britta Wahren; Gretchen Antelman; Mary Glenn Fowler; Laura Guay; J Brooks Jackson
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-01       Impact factor: 3.731

7.  Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter.

Authors:  M A Montano; C P Nixon; M Essex
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Authors:  L G Gürtler; P H Hauser; J Eberle; A von Brunn; S Knapp; L Zekeng; J M Tsague; L Kaptue
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysis.

Authors:  B Berkhout
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

10.  Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

Authors:  A K Iversen; E G Shpaer; A G Rodrigo; M S Hirsch; B D Walker; H W Sheppard; T C Merigan; J I Mullins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.